Med spas and aesthetic clinics: 30 matched rules, 11 that block approval

• Disease claims11
• State law6
• Platform policy5
• Regulatory status3
• Efficacy and proof2
• Patient quotes and reviews2
• Outcome statistics1

Federal and general rules first, blocking before warning, citations checked against stored text before the rest. Rules with their own page link there.

1. CG-DIS-019 · Blocks approval · Citation checked against stored text

   Claims to slow, stop or prevent a serious disease, or to restore function after spinal cord injury, are disease claims that need drug approval and evidence.

   Source: FDCA 201(g)(1); 21 CFR 101.93(g); FDA consumer alerts on stem cell and dietary supplement disease claims; FTC Act section 5

   Safer wording: Remove disease slowing, prevention and recovery claims. Describe a supplement by its nutrients only, and a stem cell service only as an investigational study.

   21 CFR 101.93(g) · Needs counsel review

2. CG-INF-001 · Blocks approval · Citation checked against stored text

   A free product, a commission or a code is a material connection that must be clearly disclosed, and a before-and-after claim by a paid endorser needs proof and a typical-results statement.

   Source: FTC Endorsement Guides, 16 CFR Part 255; FTC Rule on Consumer Reviews and Testimonials, 16 CFR Part 465; FTC Act section 5

   Safer wording: Put a clear disclosure of any payment, gift or commission at the start of the post, and remove unproven results claims.

   16 CFR Part 255, 16 CFR Part 465 · Needs counsel review

3. CG-RFA-002 · Blocks approval · Citation checked against stored text

   Naming a disease as what a product, formula or package is for, or calling something a natural remedy for it, is an implied claim to treat or prevent that disease.

   Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance

   Safer wording: Do not name a disease as the use of a supplement or cosmetic. Describe general wellness support only.

   21 CFR 101.93(g) · Needs counsel review

4. CG-RFA-003 · Blocks approval · Citation checked against stored text

   Anti-cancer, anti-inflammatory, immune-restoring, detox or regenerative claims describe the treatment or mitigation of disease and are unapproved drug claims when made for a supplement, cosmetic or biologic.

   Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance

   Safer wording: Remove anticancer, anti-inflammatory and regenerative claims. Do not describe the product as acting on disease processes.

   21 CFR 101.93(g) · Needs counsel review

5. CG-RFA-008 · Blocks approval · Citation checked against stored text

   Pain, itch, swelling or symptom relief claims, sexual performance and fat-loss claims describe the effect of a drug on the body and are unapproved drug claims for a supplement, cosmetic or device.

   Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance

   Safer wording: Remove the symptom-relief, sexual performance and fat-burning claims, or move the product through drug approval.

   21 CFR 101.93(g) · Needs counsel review

6. CG-STA-002 · Blocks approval · Citation checked against stored text

   Before-and-after material and personal results imply typical results and must be real, consented and fairly representative.

   Source: FTC Endorsement Guides, 16 CFR Part 255; FTC Act section 5

   Safer wording: Show what is typical, state the time frame and conditions, and keep written patient consent on file.

   16 CFR Part 255 · Needs counsel review

7. CG-TRB-013 · Blocks approval · Citation checked against stored text

   Practicing without physician oversight, injectable parties, fake board certifications, unscreened donors and urgent-care claims of emergency capability misrepresent who is providing care and are barred by state medical practice laws.

   Source: State medical practice acts and corporate practice of medicine rules; state board of medicine rules on board-certification advertising; FDA 21 CFR Part 1271 donor eligibility; FTC Act section 5

   Safer wording: Disclose the licensed supervising physician, advertise only real board certifications from recognized boards, and do not offer injectables at social events.

   21 CFR Part 1271 · Needs counsel review

8. CG-TRI-009 · Blocks approval · Citation checked against stored text

   Staging before-and-after photos with different lighting, retouching them, or showing hundreds of curated results with only a token disclaimer misrepresents the typical outcome.

   Source: FTC Endorsement Guides, 16 CFR Part 255; FTC Act section 5; state medical board rules on before-and-after photographs

   Safer wording: Use consistent lighting, angle and distance, never retouch results, and disclose the typical result and how the photos were selected.

   16 CFR Part 255 · Needs counsel review

9. CG-LIC-002 · Blocks approval

   Injectables and lasers must be performed by, or under the supervision of, a licensed clinician. Supervision and scope rules for nurse practitioners vary by state.

   Source: state medical, nursing and cosmetology practice acts (state law, varies by state); FTC Act section 5

   Safer wording: Say who performs each treatment and their license, and follow your state's supervision rules.

   See source text · Needs counsel review

10. CG-TRG-003 · Blocks approval

    Claiming that a service or product heals, fixes or reverses a named disease, quickly or at the root, is an unapproved disease treatment claim.

    Source: FDCA 201(g)(1); FTC Act section 5; FTC Health Products Compliance Guidance; FDA guidance on unapproved psychedelic and stem cell claims

    Safer wording: Remove cure, fix and reversal language. Describe the service and who delivers it, and do not promise a condition will resolve.

    See source text · Needs counsel review

Sample wording we wrote to test these rules, run through the real engine at build time. The rule ids, reasons, sources and safer wording are the rule-set's own.

4 pages below meet the gate: at least 6 applicable rules and at least 3 that belong to that state or platform alone.